Todays @mathonco research in progress is from #AndersonLab veteran and creative guru @jillagal presenting new results from our on going @EvolTherapy trial: Developing a data to decision support pipeline for advanced basal cell carcinoma adaptive therapy. pic.twitter.com/Gr9iblQLsQ
